Prudential Financial Inc Pmv Pharmaceuticals, Inc. Transaction History

Prudential Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$3.94 - $6.27 $131,438 - $209,167	33,360 New	33,360 $208,000
Q2 2022 Aug 15, 2022	SELL	$9.23 - $22.43 $469,114 - $1.14 Million	-50,825 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$19.99 - $30.24 $20,849 - $31,540	-1,043 Reduced 2.01%	50,825 $1.2 Million
Q3 2021 Nov 15, 2021	BUY	$26.84 - $36.58 $481,778 - $656,611	17,950 Added 52.92%	51,868 $1.55 Million
Q2 2021 Aug 16, 2021	BUY	$28.01 - $36.01 $47,701 - $61,325	1,703 Added 5.29%	33,918 $1.16 Million
Q1 2021 May 12, 2021	BUY	$30.66 - $49.5 $987,711 - $1.59 Million	32,215 New	32,215 $1.06 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.